Cargando…
High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot
BACKGROUND: Prostate cancer (PCa) has a profoundly immunosuppressive microenvironment and is commonly immune excluded with few infiltrative lymphocytes and low levels of immune activation. High-dose radiation has been demonstrated to stimulate the immune system in various human solid tumors. We hypo...
Autores principales: | Keam, Simon P, Halse, Heloise, Nguyen, Thu, Wang, Minyu, Van Kooten Losio, Nicolas, Mitchell, Catherine, Caramia, Franco, Byrne, David J, Haupt, Sue, Ryland, Georgina, Darcy, Phillip K, Sandhu, Shahneen, Blombery, Piers, Haupt, Ygal, Williams, Scott G, Neeson, Paul J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319782/ https://www.ncbi.nlm.nih.gov/pubmed/32581061 http://dx.doi.org/10.1136/jitc-2020-000792 |
Ejemplares similares
-
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival
por: Freudenstein, Donald, et al.
Publicado: (2020) -
Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes
por: Trigos, Anna Sofia, et al.
Publicado: (2022) -
Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment
por: Pizzolla, Angela, et al.
Publicado: (2022) -
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report
por: Williams, Scott G., et al.
Publicado: (2020) -
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss
por: Mejía-Hernández, Javier Octavio, et al.
Publicado: (2022)